Lopreeza Tablet, Film Coated
Pricing Report NDC 69238-1610-6

Latest NADAC: $1.08479 per EA · Effective Apr 20, 2022 · Est. package price $1.08 (1 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Lopreeza (NDC 69238-1610-6) is $1.08479 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 20, 2022.

As a a human prescription drug provided by Amneal Pharmaceuticals Ny Llc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 28 TABLET, FILM COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.08479
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 20, 2022
Billable Units
1 EA
Estimated Package Price
$1.08
Data Status
As of Apr 27, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
69238-1610-6
Description
1 BLISTER PACK in 1 CARTON / 28 TABLET, FILM COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2019, the NADAC wholesale price for (NDC ) has moved within a range of $1.03949 to $2.24933 per EA. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.0395 - $2.2493
Market Volatility
116.39% Variance
Latest Trend
3.00%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 20, 2022 $1.08479 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $1.11831 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $1.08942 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $1.19426 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $1.03949 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $1.34881 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $1.42718 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $1.44777 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 18, 2021 $1.19239 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $1.57554 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 23, 2021 $1.79638 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 19, 2021 $1.66497 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026